Results 261 to 270 of about 2,029,665 (367)

Interfacial Roughness‐Reinforced Magnetic Nanosheet Colloidal Gels for Stable Embolization and Magnetothermal Therapy of Hepatic Tumor

Advanced Science, EarlyView.
A rough‐interface reinforcement strategy is implemented to construct nanosheet‐mica‐based magnetic colloidal hydrogels with enhanced mechanical robustness and injectability. These hydrogels achieve stable vascular embolization and effective magnetothermal performance, offering synergistic therapeutic benefits in hepatic tumor treatment.
Xingyu Liu, Sheng Chen, Yonghong Song, Bing Chen, Xu Yan, Rui Qiu, Jinlong Hu, Baoqiang Cao, Hanye Xing, Tao Zhou, Liang Dong, Yang Lu   +11 more
wiley   +1 more source

Addressing the Unmet Need for Treatment in Advanced Hepatocellular Carcinoma With Child-Pugh C Cirrhosis: A Case of a Woman With Hepatocellular Carcinoma and Advanced Liver Disease. [PDF]

Cureus
Chamberlain E, Cleveland JM.
europepmc   +1 more source

Cranial Metastasis of Hepatocellular Carcinoma

, 1985
Satoshi Nakao, Shinichi Sato, T Fukumitsu, M Ogata, Hirofumi Shirane   +4 more
openalex   +2 more sources

Hepatocellular carcinoma arising in noncirrhotic and highly cirrhotic livers: A comparative study of histopathology and frequency of hepatitis B markers [PDF]

, 1982
Kunio Okuda, Toshiro Nakashima, Kazuyoshi Sakamoto, T. Ikari, Hisamitsu Hidaka, Yasuhiko Kubo, Koshi Sakuma, Yoji Motoike, Hiroaki Okuda, Hiroshi Obata   +9 more
openalex   +1 more source

PLAUR+ Neutrophils Drive Anti‐PD‐1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment

Advanced Science, EarlyView.
The present study reveals that PLAUR+ neutrophils are enriched in immunotherapy non‐responders and correlate with poor prognosis. PLAUR+ neutrophils dictate immunotherapy resistance in hepatocellular carcinoma by forming an immunosuppressive tumor microenvironment characterized by CD8+ T cell exclusion and macrophage‐dependent immune suppression.
Shaoqing Liu, Yanzhao Zhou, Gaoxiang Li, Bingwen Zhu, Fang Wu, Jinxue Zhou, Xiaobing Chen, Bo Qin, Yanxia Gao, Fazhan Wang, Yong Jiang, Wenxin Xu   +11 more
wiley   +1 more source

Hepatocellular carcinoma in patients without cirrhosis. [PDF]

World J Gastroenterol
Sato-Espinoza K, Valdivia-Herrera M, Chotiprasidhi P, Diaz-Ferrer J.   +3 more
europepmc   +1 more source

Lymphokine-activated killer activity and natural killer activity in patients with hepatocellular carcinoma.

, 1987
Hiroshi SAKAEDA, Toshiji Saibara, Saburo Onishi   +2 more
openalex   +2 more sources

Epidemiology and surveillance for hepatocellular carcinoma: New trends.

Journal of Hepatology, 2020
A. Singal, P. Lampertico, P. Nahon
semanticscholar   +1 more source

Long Non‐Coding RNA IGFRIL Couples with PTBP1 to Destabilize IGFBP3 mRNA to Promote the IGF1R‐AKT‐mTOR Axis and Hepatocellular Carcinoma

Advanced Science, EarlyView.
The limited understanding of IGFR pathway activation hinders its clinical application in HCC. Here, IGFRIL is identified as a novel non‐coding activator of the IGF1R, which recruits PTBP1 to destabilize IGFBP3 mRNA and activates IGF1R, and proposes IGFRIL as a novel actionable target for HCC patients.
Jing Zhang, Chengming Gao, Haibei Li, Yuying Chen, Liting Yang, Qian Jin, Lan Feng, Xia Wang, Xinyi Liu, Hongxia Chen, Rong Ye, Yuanchao Xue, Huiyun Wang, Musheng Zeng, Ming Yang, Huaiqiang Ju, Chengzhi Gao, Guangming Zhou, Qi Zhang, Qian Zhang, Geng Qin, Yuanfeng Li, Yahui Wang, Aiqing Yang, Anfeng Si, Qingfeng Song, Fuchu He, Pengbo Cao, Gangqiao Zhou   +28 more
wiley   +1 more source

Percutaneous injection of adriamycin-lipiodol emulsion into hepatocellular carcinoma tumor nodules demonstrates lymph vessels connecting the tumor and the regional lymph nodes.

, 1987
Hirotomo Saitsu, Masamichi Kojiro, Satoru TANIWAKI, Hiroaki Yoshida, Kouji Yoshida, Toshimichi Nakayama, Kiroku Ohishi   +6 more
openalex   +2 more sources